Start Date
January 31, 2023
Primary Completion Date
May 31, 2023
Study Completion Date
May 31, 2023
ADX-629
ADX-629 (250 milligrams) administered twice daily
East Carolina University - Nephrology, Greenville
ClinCept, LLC, Bremen
Emory University - Pediatric Nephrology, Atlanta
South Florida Research Institute, Lauderdale Lakes
The Ohio State University (OSU) Wexner Medical Center, Columbus
University of Toledo Medical Center, Toledo
Northwest Louisiana Nephrology, Shreveport
University of Colorado, Aurora
Southern Utah Kidney and Hypertension Center, St. George
Nevada Kidney Disease Hypertension Center (NKDHC), Las Vegas
Amicis Research Center - Northridge, Northridge
Lead Sponsor
Aldeyra Therapeutics, Inc.
INDUSTRY